Galectin Therapeutics (GALT) Shareholder's Equity Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Galectin Therapeutics | 165.77 Mn | 151.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.77% |
| Dec 31, 2025 | -22.07% |
| Sep 30, 2025 | -33.01% |
| Jun 30, 2025 | -41.76% |
| Mar 31, 2025 | -156.90% |
| Dec 31, 2024 | -69.12% |
| Sep 30, 2024 | -79.11% |
| Jun 30, 2024 | -58.69% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | -82.69% |
| Sep 30, 2023 | -118.62% |
| Jun 30, 2023 | -211.87% |
| Mar 31, 2023 | -460.50% |
| Dec 31, 2022 | -3,898.10% |
| Sep 30, 2022 | -419.67% |
| Jun 30, 2022 | -210.09% |
| Mar 31, 2022 | -147.94% |
| Dec 31, 2021 | -96.03% |
| Sep 30, 2021 | -74.76% |
| Jun 30, 2021 | -56.38% |
| Mar 31, 2021 | -59.76% |
| Dec 31, 2020 | -48.78% |
| Sep 30, 2020 | -37.56% |
| Jun 30, 2020 | -29.28% |
| Mar 31, 2020 | 701.52% |
| Dec 31, 2019 | 747.77% |
| Sep 30, 2019 | 559.20% |
| Jun 30, 2019 | 519.70% |
| Mar 31, 2019 | 453.41% |
| Dec 31, 2018 | 1,076.42% |
| Sep 30, 2018 | 665.05% |
| Jun 30, 2018 | 96.68% |
| Mar 31, 2018 | -88.31% |
| Dec 31, 2017 | -105.15% |
| Sep 30, 2017 | -90.81% |
| Jun 30, 2017 | -45.32% |
| Mar 31, 2017 | -36.56% |
| Dec 31, 2016 | -42.95% |
| Sep 30, 2016 | -19.71% |
| Jun 30, 2016 | -58.12% |
| Mar 31, 2016 | -42.91% |
| Dec 31, 2015 | -14.89% |
| Sep 30, 2015 | -44.72% |
| Jun 30, 2015 | -30.50% |
| Mar 31, 2015 | -22.71% |
| Dec 31, 2014 | 1,331.13% |
| Sep 30, 2014 | 1,685.92% |
| Jun 30, 2014 | 932.76% |
| Mar 31, 2014 | 2,828.38% |
| Dec 31, 2013 | 27.12% |
| Sep 30, 2013 | -57.47% |
| Jun 30, 2013 | -162.96% |
| Mar 31, 2013 | -115.18% |
| Dec 31, 2012 | 154.82% |
| Sep 30, 2012 | 271.45% |
| Jun 30, 2012 | 436.17% |
| Dec 31, 2011 | -25.44% |